Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012
Topics: Autoimmune, Drug Discovery
|
Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2012
Topics: Autoimmune, Clinical Trial
Regions: Global
|
Chronic Plaque Psoriasis – Pipeline Review, H2 2012
Topics: Autoimmune, Drug Discovery
|
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)
Topics: Research & Development, Stem Cell, Autoimmune, Cardiovascular, Infectious Diseases, Oncology/Hematology
|
Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment
Topics: Biologics, Autoimmune, Research & Development, Drug Discovery, Biopharmaceuticals, Dermatology
|
Moderate Psoriasis – Pipeline Review, H2 2012
Topics: Autoimmune, Drug Discovery
|
Severe Psoriasis – Pipeline Review, H2 2012
Topics: Autoimmune, Drug Discovery
|
Systemic Lupus Erythematosus – Pipeline Review, H2 2012
Topics: Autoimmune, Drug Discovery
|
Psoriasis – Pipeline Review, H2 2012
Topics: Autoimmune, Drug Discovery
|
Autoimmune Disorders – Pipeline Review, H2 2012
Topics: Autoimmune, Drug Discovery
|
Intravenous Immunoglobulin (IVIg)
Topics: Antibody Technologies, Autoimmune, Needles, Syringes, IV Access
Regions: Global
|
Psoriasis Pipeline Perspectives Report - Intracellular Signaling Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report - Direct Inflammatory Cytokine Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report - T-cell Activation Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report - T-cell Migration Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Pipeline Perspectives Report - Inflammatory Cytokine Blockers
Topics: Autoimmune, Drug Discovery
|
Psoriasis Market Info™ - Updated for 2012
Topics: Autoimmune, Research & Development, Drug Discovery
|
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
Topics: Autoimmune, Multiple Sclerosis (MS), Research & Development
|
Psoriasis Global Clinical Trials Review, H1, 2012
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: Global
|
Treatment Algorithms: Psoriasis – Prescribing trends mirror guidelines
Topics: Autoimmune, Drug Discovery
|
Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success
Topics: Autoimmune, Clinical Trial
|
Liver Disease Treatments: The Global Market
Topics: Hepatitis, Autoimmune, Vaccines
Regions: Global
|
Celiac Disease - Pipeline Assessment and Market Forecasts to 2019
Topics: Autoimmune, Drug Discovery
|
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Topics: Antibody Technologies, Autoimmune
|
Market and Product Forecasts: Psoriasis – Novel products and current biologics to fuel future market growth
Topics: Biologics, Autoimmune, Drug Discovery, Biopharmaceuticals
|
Psoriasis Market Forecast
Topics: Autoimmune, Drug Discovery
|
Auto Inflammatory Disease - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Topics: Autoimmune, Research & Development
|
Systemic Lupus Erythematosus Therapeutics (SLE) - Pipeline Assessment and Market Forecasts to 2018
Topics: Autoimmune, Drug Discovery
|
Neuromodulation Devices: World Market Prospects 2011-2021
Topics: Autoimmune, Medical Devices, Orthopedics
|
Drugs and Treatments for Autoimmune Diseases: Global Markets
Topics: Autoimmune
Regions: Global
|
Celiac Disease - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth
Topics: Autoimmune, Research & Development, Drug Discovery
|
Autoimmune Market Access in China - New biologic therapies drive future growth
Topics: Autoimmune
Regions: China
|
Autoimmune Market Access in China – New biologic therapies drive future growth
Topics: Autoimmune, Manufacturing, Packaging & Detailing, Drug Discovery
Regions: China
|
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Topics: Autoimmune, Clinical Trial
|
Report: Do the Emerging Treatments for Celiac Disease Offer Significant Improvements over the Gluten-Free Diet?
Topics: Genomics, Autoimmune, Drug Discovery
|
Strategic Overview of the Autoimmune Biologics Market
Topics: Autoimmune, Research & Development
|
Chronic Plaque Psoriasis - Pipeline Review, H2 2011
Topics: Autoimmune, Drug Discovery
|
Market and Product Forecasts: Systemic Lupus Erythematosus – Benlysta approval kicks off new era in lupus treatment
Topics: Autoimmune, Research & Development, Drug Discovery
|
Special Report: The Autoimmune Biologics Pipeline—A Competitive Review
Topics: Autoimmune, Research & Development
|
Special Report: The Pricing and Reimbursement Environment for Autoimmune Biologics
Topics: Autoimmune, Pricing
|
ProtAb Private Vendor Watchlist Profile: Therapeutic Antibodies for Treating Autoimmune Diseases
Topics: Antibody Technologies, Autoimmune
|
Product Profiles: Systemic Lupus Erythematosus - Benlysta approval brings lessons and hope to market
Topics: Autoimmune, Drug Discovery, Clinical Trial
|
Chronic Plaque Psoriasis Global Clinical Trials Review, Q2, 2011
Topics: Autoimmune, Drug Discovery
|
Systemic Lupus Erythematosus Global Clinical Trials Review, Q2, 2011
Topics: Autoimmune, Drug Discovery
|
Celiac Disease Global Clinical Trials Review, Q2, 2011
Topics: Autoimmune, Drug Discovery
|
Use of Biomarkers to Predict Response to Biologics Therapy in Autoimmune Diseases
Topics: Biomarkers, Autoimmune
|
